Skin CancerICARUSNCT07510061
Title: ICARUS - Psycho-physiological Profiling of Low and High Heat-resilient Individuals
A study of Skin Cancer and Heat Tolerance, run by University of Thessaly at 2 sites in 2 countries.
Trial summary
The escalating environmental heat-stress associated with global warming is a societal challenge with large and potential harmful consequences for humans. Excess morbidity and mortality during heat waves provides strong evidence for fatal outcomes. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Skin Cancer, Heat Tolerance, Heat-related Illness
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 80 participants
- Where
- 2 sitesin 2 countries
- Study dates
- 1 Nov 2025to 30 Apr 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age 18-65 years (or your protocol-specific age range)
- Healthy as determined by medical history screening questionnaire
- Able to provide written informed consent
- Able to complete heat exposure and light exercise protocol
- No heat acclimatization or extensive sun exposure in the previous 4 weeks
- Fitzpatrick skin type I-IV (if applicable for UV testing)
- Willing to undergo blood sampling, urine collection, and skin biopsy
Who cannot join
- History of cardiovascular, metabolic, neurological, or dermatological disease
- History of heat-related illness (e.g., heat stroke)
- Use of medications affecting thermoregulation or cardiovascular function
- Smoking or substance abuse
- Pregnancy or breastfeeding
- Abnormal ECG or uncontrolled hypertension
Show all 9Show fewer
- Recent severe sunburn or UV treatment
- Contraindications to skin biopsy
- Inability to tolerate heat exposure during screening
Trial locations and contacts
2 sites in 2 countries. Contact the study team or a site near you to ask about taking part.
2 sites in 2 countries
Denmark1 site, 1 recruiting
- Recruiting
Københavns Universitet
Copenhagen, 2100
Mathilde Lund, PhD, 60701892 ext. +45, mathilde.lund@nexs.ku.dk
Mathilde Lund, MSc
Greece1 site, 1 recruiting
- Recruiting
Department of Physical Education and Sport Science
Trikala, Thessaly, 42100
Maria Vliora, PhD, 6979642540 ext. +30, mvliora@gmail.com
Konstantinos Mantzios, PhD, 6948626874 ext. +30, konstantinosmantzios@gmail.com
About this study
Official title: Physiological Phenotyping
The escalating environmental heat-stress associated with global warming is a societal challenge with large and potential harmful consequences for humans. Excess morbidity and mortality during heat waves provides strong evidence for fatal outcomes. However, it is unclear why some people are particularly vulnerable and get sick from hyperthermia, while others adapt and tolerate exposure.
The Icarus project aims to provide a psycho-physiological framework for improved mitigation of the health threats associated with global warming. Combining expertise in integrative thermal physiology, pharmacology, photobiology, psychology and machine learning, we will collaborate on comprehensive cross-scientific studies using controlled lab-exposure combined with investigations in ecological settings including vulnerable and highly tolerant people across populations from northern to southern Europe.
Read more
Advanced algorithms will be developed to generate personalized alerts and advising based on behavioral patterns, psychological profiling, predicted vulnerability and willingness to adopt resilience-building strategies.
Global warming is projected to continue towards the end of the 21st century and constitutes an increasing threat to human health unless we as individuals and collectively become better in preventing acute effects, as well as devise sustainable strategies to limit further anthropogenic warming of the climate system. Acutely, improved guidance is important for both individual and public health, where Icarus aims at providing a highly improved basis for preventing heat-related disease, advising or nudging people towards pro-health behavior, including smarter use of technologies to mitigate heat stress, or adjusting medication to reduce adverse effects during heat events. In support of the sustainability agenda, our framework also forms a novel basis for developing advising algorithms relevant for optimization of climate change mitigation policy-making.
Read the detailed description
Warming of the climate system is ongoing and there is strong evidence for detrimental effects of environmental heat stress on human with impact on public health and quality of life for billions of people globally - with the most damaging effects on societies in the hottest parts of the world. However, recent heatwaves in Canada, USA, and Northern Europe saw temperatures surpassing 40°C. Documented impacts on mortality show how climate change and the associated geographical spread of heatwaves also have health consequences in regions previously spared from high temperatures. At the same time, cutaneous melanoma already is a documented and increasing public health concern and characterized by high incidence in fair-skinned populations of European descent, particularly in Central and North European countries. The incidence of 29.7 per 100,000 person-years in Denmark is the 3rd highest globally, compared to the world average of 3.4. Alarmingly, the World Health Organization (WHO) projects that the number of new cases of melanoma per year will increase by more than 50% from 2020 to 2040.
It is abundantly clear that certain populations are more vulnerable to global warming and that certain individuals within each population are more susceptible to heat-stress than others. In the Icarus project, we will find ways to identify these people and at a large scale protect using predictive algorithms. Achieving this ambition may save lives, reduce the burden on healthcare systems, support the global sustainability agenda including UN defined sustainability goals such as the prevention of poverty via improved productivity. Thus, public health, sustainability and economic benefits from this ambitious project are clear should it succeed.
The fatal outcome of exposure to extreme heat and sunlight, as described in the myth about Icarus and scientifically documented with epidemiological evidence for excess death rates during heatwaves is, however, only the tip of the iceberg in terms of public health problems and societal impact imposed by global warming. We have documented the occupational health burden, productivity losses and economic costs associated with elevated environmental heat and we have shed light on the interaction between heat stress and exposure to solar radiation. The later with major isolated health effects of ultraviolet radiation (UVR) on the skin. Our pilot observations from combined heat-radiation exposure studies indicate that some individuals, both before and after acclimatization, are very tolerant and show almost no detrimental effects on motor-cognitive performance; while others (healthy; matched for fitness and age) show drastic changes in clinical outcomes and major declines in physical and mental performance. It is well known that sunlight exposure, and in particular certain UVR wavelengths, has direct damaging effects on the skin, but there is a large knowledge gap on its interaction with thermal physiological effects. Also, there is no research on acclimatization effects and very limited understanding of the interaction between impacts on cognitive function and psychological/behavioral factors. This is central for understanding heat vulnerability at the individual level and how it subsequently affects public health - as those at highest risk become ill, hospitalized, or add to the mortality statistics. Furthermore, these interactions are fundamental for the development of a psychophysical framework and improve the ability to understand and subsequently influence collective behavior, which is highly relevant for the implementation of policies and climate change mitigation strategies.
Differences in heat vulnerability are also observed at the population-level with markedly lower temperature thresholds for excess mortality in North compared to South European countries, but it is largely unknown if this pronounced difference in heat resilience relates to a superior "physiological defense system" in South Europeans orprimarily relates to different social experiences of heat and thus different behaviors i.e., more appropriate thermoregulatory behavior in South Europeans. Higher risk taking (e.g., inappropriate "sun-bathing culture") is also a highly relevant factor in terms of skin damage (DNA mutation and photocarcinogenesis) and the associated risk for developing skin cancer. For instance, in a recent pilot study, we observed a 10-fold higher excretion of cyclobutane thymine dimers in the urine (as a marker of skin DNA damage) of Danish volunteers after a winter vacation to a sunny region, compared to their peers who freely chose to be less exposed.
Analogous to the mythical Icarus, who flew too close to the sun, our recent pilot data individual data from papers by our consortium show that vulnerable people, collectively translating into differences at the population level, arenot able to sense and comprehend the danger associated with exposure to solar radiation. If we - unlike Icarus' father - are to become better at protecting individuals atrisk and advise humanity at large, we need an improved and interdisciplinary approach to mitigate and understand the risks imposed by escalating environmental heat exposure.
The Icarus project will generate a psycho-physical framework for improved ability tomitigate the threats associated with increased exposure aggravated by global warming: from individual vulnerability to heat and sun exposure, to public health and collective behavior. The developed framework shall allow us to identify patterns and develop algorithms for early detection of those susceptible to becoming sick from heat and sun exposure. This may directly benefit public health as well as bridge the gap from individual to collective behavior which has relevance for policy-making and climate change mitigation. To achieve the ambitious overall aim, we have composed a consortium led by experts in thermal physiology, psychology, dermatology, pharmacological prevention of adverse effects from sunlight exposure, as well as artificial intelligence and machine learning - allowing us to complete the inter-disciplinary studies and sub-tasks.
- Conditions
- Skin Cancer, Heat Tolerance, Heat-related Illness, Hyperthermia, Heat Stress, Ultraviolet Radiation-Related Skin Damage
- Being tested
- Controlled Heat and Ultraviolet Radiation Exposure Protocol
- Keywords
- Heat Stress, Heat-Related Illness, Heat Vulnerability, Heat Intolerance, Hyperthermia, Environmental Heat Exposure, Thermal Stress, Ultraviolet Radiation Exposure, Skin DNA Damage, Cardiovascular Strain (Heat-Induced), Cognitive Impairment (Heat-Induced), Occupational Heat Stress, Climate Change and Health, Heat Resilience, Heat Acclimatization
- Medical subject headings
- Skin Neoplasms, Hyperthermia, Heat Stress Disorders, Cognitive Dysfunction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Controlled Heat and Ultraviolet Radiation Exposure ProtocolOther
Also called Standardized Heat Stress Protocol, Simulated Solar Radiation Exposure
Participants undergo a standardized 4-hour laboratory-based environmental exposure protocol consisting of passive heat exposure (40°C, 30% relative humidity), simulated solar ultraviolet radiation (up to 3 Standard Erythema Doses), light exercise-induced heat stress using a cycle ergometer, and recovery. Physiological, cardiovascular, thermoregulatory, biochemical, and psychological responses are assessed repeatedly throughout the protocol. The intervention is designed to quantify individual heat tolerance and combined heat-UV physiological strain under controlled conditions.
| Study group | Role | What they receive |
|---|---|---|
| Standardized Heat and UV Exposure Protocol | Experimental | Participants undergo a standardized 4-hour laboratory protocol to assess physiological and psychological responses to controlled heat and ultraviolet radiation exposure. The protocol includes passive heat exposure (40°C, 30% relative humidity), simulated solar UV radiation (up to 3 Standard Erythema Doses), light exercise-induced heat stress, and recovery. Core and skin temperature, cardiovascular and thermoregulatory responses, orthostatic tolerance, echocardiography, blood and urine biomarkers, skin biopsies, motor-cognitive performance, and psychological measures are assessed repeatedly. Subgroup analyses compare participants by geographic location (Denmark vs Greece) and pre-defined heat tolerance status (low vs high). Receives: Other: Controlled Heat and Ultraviolet Radiation Exposure Protocol |
What is being measured
The primary outcome is the main question the study is designed to answer.
Physiological Heat Tolerance
Maximum tolerable exposure time during the standardized heat and ultraviolet radiation protocol. (units of measure: Minutes)
Measured: During 4-hour laboratory protocol
Heart Rate Response
Heart rate measured continuously during heat and UV exposure to assess cardiovascular strain [unit: beats per minute (bpm)]
Measured: During 4-hour laboratory protocol
Secondary outcomes (4)
Blood Pressure Response
Stroke volume assessed to evaluate cardiac function during environmental stress (unit: mL/beat)
Measured: During 4-hour laboratory protocol
Cardiac Output
Ability to maintain blood pressure and consciousness during postural change following exposure (unit : L/min)
Measured: During 4-hour laboratory protocol
Orthostatic Tolerance
Ability to maintain blood pressure and consciousness during postural change following exposure [unit: time to presyncope (minutes)]
Measured: Every 60 min during the protocol
Echocardiographic Parameters
Cardiac structure and function assessed via echocardiography (ejection fraction) (unit:%)
Measured: Every 60 min during the protocol
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Apr 2026
- Study start1 Nov 2025
- Primary completion30 Apr 2027 (estimated)
- Study completion30 Apr 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Skin CancerStudies of the same condition, open and under way.
- More trials run by University of ThessalyThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Participants are assigned to predefined groups based on geographic location (Denmark or Greece) and heat tolerance status (low or high). All groups undergo the same standardized laboratory heat and UV exposure protocol for comparative physiological and psychological phenotyping.
- Masking
- None (open label)
- Enrolment
- 80 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Thessaly
- Sponsor type
- University, hospital or other
- Collaborators
- University of Copenhagen, Bispebjerg Hospital
- Responsible party
- Principal investigator, Georgia Ntina, University of Thessaly
- Investigators
- Andreas D Flouris, PhD, Principal investigator, 1FAME Laboratory, Department of Exercise Science, University of Thessaly, Trikala, GreeceLars Nybo, PhD, Principal investigator, Department of Nutrition, Exercise and Sports, August Krogh Building, University of Copenhagen, Copenhagen, Denmark.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07510061
- Sponsor's protocol ID
- 03/07.02.2025
- Acronym
- ICARUS
- Status last verified
- Mar 2026
- First submitted
- 20 Feb 2026
- Last updated
- 3 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Physiological Phenotyping
- ClinicalTrials.gov ID
- NCT07510061
- Acronym / sponsor ID
- ICARUS / 03/07.02.2025
- Conditions
- Skin Cancer, Heat Tolerance, Heat-related Illness, Hyperthermia, Heat Stress, Ultraviolet Radiation-Related Skin Damage
- Keywords
- Heat Stress, Heat-Related Illness, Heat Vulnerability, Heat Intolerance, Hyperthermia, Environmental Heat Exposure, Thermal Stress, Ultraviolet Radiation Exposure
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 80 participants (estimated)
- Lead sponsor
- University of ThessalyUniversity, hospital or other
- Collaborators
- University of Copenhagen, Bispebjerg Hospital
- Study start
- 1 Nov 2025 (actual)
- Primary completion
- 30 Apr 2027 (estimated)
- Study completion
- 30 Apr 2027 (estimated)
- First posted
- 3 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The escalating environmental heat-stress associated with global warming is a societal challenge with large and potential harmful consequences for humans. Excess morbidity and mortality during heat waves provides strong evidence for fatal outcomes. However, it is unclear why some people are particularly vulnerable and get sick from hyperthermia, while others adapt and tolerate exposure.
The Icarus project aims to provide a psycho-physiological framework for improved mitigation of the health threats associated with global warming. Combining expertise in integrative thermal physiology, pharmacology, photobiology, psychology and machine learning, we will collaborate on comprehensive cross-scientific studies using controlled lab-exposure combined with investigations in ecological settings including vulnerable and highly tolerant people across populations from northern to southern Europe.
Advanced algorithms will be developed to generate personalized alerts and advising based on behavioral patterns, psychological profiling, predicted vulnerability and willingness to adopt resilience-building strategies.
Global warming is projected to continue towards the end of the 21st century and constitutes an increasing threat to human health unless we as individuals and collectively become better in preventing acute effects, as well as devise sustainable strategies to limit further anthropogenic warming of the climate system. Acutely, improved guidance is important for both individual and public health, where Icarus aims at providing a highly improved basis for preventing heat-related disease, advising or nudging people towards pro-health behavior, including smarter use of technologies to mitigate heat stress, or adjusting medication to reduce adverse effects during heat events. In support of the sustainability agenda, our framework also forms a novel basis for developing advising algorithms relevant for optimization of climate change mitigation policy-making.
Detailed description
Warming of the climate system is ongoing and there is strong evidence for detrimental effects of environmental heat stress on human with impact on public health and quality of life for billions of people globally - with the most damaging effects on societies in the hottest parts of the world. However, recent heatwaves in Canada, USA, and Northern Europe saw temperatures surpassing 40°C. Documented impacts on mortality show how climate change and the associated geographical spread of heatwaves also have health consequences in regions previously spared from high temperatures. At the same time, cutaneous melanoma already is a documented and increasing public health concern and characterized by high incidence in fair-skinned populations of European descent, particularly in Central and North European countries. The incidence of 29.7 per 100,000 person-years in Denmark is the 3rd highest globally, compared to the world average of 3.4. Alarmingly, the World Health Organization (WHO) projects that the number of new cases of melanoma per year will increase by more than 50% from 2020 to 2040.
It is abundantly clear that certain populations are more vulnerable to global warming and that certain individuals within each population are more susceptible to heat-stress than others. In the Icarus project, we will find ways to identify these people and at a large scale protect using predictive algorithms. Achieving this ambition may save lives, reduce the burden on healthcare systems, support the global sustainability agenda including UN defined sustainability goals such as the prevention of poverty via improved productivity. Thus, public health, sustainability and economic benefits from this ambitious project are clear should it succeed.
The fatal outcome of exposure to extreme heat and sunlight, as described in the myth about Icarus and scientifically documented with epidemiological evidence for excess death rates during heatwaves is, however, only the tip of the iceberg in terms of public health problems and societal impact imposed by global warming. We have documented the occupational health burden, productivity losses and economic costs associated with elevated environmental heat and we have shed light on the interaction between heat stress and exposure to solar radiation. The later with major isolated health effects of ultraviolet radiation (UVR) on the skin. Our pilot observations from combined heat-radiation exposure studies indicate that some individuals, both before and after acclimatization, are very tolerant and show almost no detrimental effects on motor-cognitive performance; while others (healthy; matched for fitness and age) show drastic changes in clinical outcomes and major declines in physical and mental performance. It is well known that sunlight exposure, and in particular certain UVR wavelengths, has direct damaging effects on the skin, but there is a large knowledge gap on its interaction with thermal physiological effects. Also, there is no research on acclimatization effects and very limited understanding of the interaction between impacts on cognitive function and psychological/behavioral factors. This is central for understanding heat vulnerability at the individual level and how it subsequently affects public health - as those at highest risk become ill, hospitalized, or add to the mortality statistics. Furthermore, these interactions are fundamental for the development of a psychophysical framework and improve the ability to understand and subsequently influence collective behavior, which is highly relevant for the implementation of policies and climate change mitigation strategies.
Differences in heat vulnerability are also observed at the population-level with markedly lower temperature thresholds for excess mortality in North compared to South European countries, but it is largely unknown if this pronounced difference in heat resilience relates to a superior "physiological defense system" in South Europeans orprimarily relates to different social experiences of heat and thus different behaviors i.e., more appropriate thermoregulatory behavior in South Europeans. Higher risk taking (e.g., inappropriate "sun-bathing culture") is also a highly relevant factor in terms of skin damage (DNA mutation and photocarcinogenesis) and the associated risk for developing skin cancer. For instance, in a recent pilot study, we observed a 10-fold higher excretion of cyclobutane thymine dimers in the urine (as a marker of skin DNA damage) of Danish volunteers after a winter vacation to a sunny region, compared to their peers who freely chose to be less exposed.
Analogous to the mythical Icarus, who flew too close to the sun, our recent pilot data individual data from papers by our consortium show that vulnerable people, collectively translating into differences at the population level, arenot able to sense and comprehend the danger associated with exposure to solar radiation. If we - unlike Icarus' father - are to become better at protecting individuals atrisk and advise humanity at large, we need an improved and interdisciplinary approach to mitigate and understand the risks imposed by escalating environmental heat exposure.
The Icarus project will generate a psycho-physical framework for improved ability tomitigate the threats associated with increased exposure aggravated by global warming: from individual vulnerability to heat and sun exposure, to public health and collective behavior. The developed framework shall allow us to identify patterns and develop algorithms for early detection of those susceptible to becoming sick from heat and sun exposure. This may directly benefit public health as well as bridge the gap from individual to collective behavior which has relevance for policy-making and climate change mitigation. To achieve the ambitious overall aim, we have composed a consortium led by experts in thermal physiology, psychology, dermatology, pharmacological prevention of adverse effects from sunlight exposure, as well as artificial intelligence and machine learning - allowing us to complete the inter-disciplinary studies and sub-tasks.
Study design
- Primary purpose
- Screening
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Participants are assigned to predefined groups based on geographic location (Denmark or Greece) and heat tolerance status (low or high). All groups undergo the same standardized laboratory heat and UV exposure protocol for comparative physiological and psychological phenotyping.
| Arm | Type | Receives |
|---|---|---|
| Standardized Heat and UV Exposure Protocol | Experimental | Other: Controlled Heat and Ultraviolet Radiation Exposure ProtocolParticipants undergo a standardized 4-hour laboratory protocol to assess physiological and psychological responses to controlled heat and ultraviolet radiation exposure. The protocol includes passive heat exposure (40°C, 30% relative humidity), simulated solar UV radiation (up to 3 Standard Erythema Doses), light exercise-induced heat stress, and recovery. Core and skin temperature, cardiovascular and thermoregulatory responses, orthostatic tolerance, echocardiography, blood and urine biomarkers, skin biopsies, motor-cognitive performance, and psychological measures are assessed repeatedly. Subgroup analyses compare participants by geographic location (Denmark vs Greece) and pre-defined heat tolerance status (low vs high). |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Age 18-65 years (or your protocol-specific age range)
- Healthy as determined by medical history screening questionnaire
- Able to provide written informed consent
- Able to complete heat exposure and light exercise protocol
- No heat acclimatization or extensive sun exposure in the previous 4 weeks
Key exclusion criteria (9 listed)
- History of cardiovascular, metabolic, neurological, or dermatological disease
- History of heat-related illness (e.g., heat stroke)
- Use of medications affecting thermoregulation or cardiovascular function
- Smoking or substance abuse
- Pregnancy or breastfeeding
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Controlled Heat and Ultraviolet Radiation Exposure ProtocolAlso: Standardized Heat Stress Protocol, Simulated Solar Radiation ExposureParticipants undergo a standardized 4-hour laboratory-based environmental exposure protocol consisting of passive heat exposure (40°C, 30% relative humidity), simulated solar ultraviolet radiation (up to 3 Standard Erythema Doses), light exercise-induced heat stress using a cycle ergometer, and recovery. Physiological, cardiovascular, thermoregulatory, biochemical, and psychological responses are assessed repeatedly throughout the protocol. The intervention is designed to quantify individual heat tolerance and combined heat-UV physiological strain under controlled conditions. | Other | Standardized Heat and UV Exposure Protocol |
Primary outcome
Physiological Heat Tolerance
Time frame: During 4-hour laboratory protocol
Maximum tolerable exposure time during the standardized heat and ultraviolet radiation protocol. (units of measure: Minutes)
Heart Rate Response
Time frame: During 4-hour laboratory protocol
Heart rate measured continuously during heat and UV exposure to assess cardiovascular strain [unit: beats per minute (bpm)]
4 secondary outcomes
Blood Pressure Response
Time frame: During 4-hour laboratory protocol
Cardiac Output
Time frame: During 4-hour laboratory protocol
Orthostatic Tolerance
Time frame: Every 60 min during the protocol
Echocardiographic Parameters
Time frame: Every 60 min during the protocol
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Apr 2026.
- Individual participant dataSharing planned: No
Related trials for Skin Cancer
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingPhase 1
IL-17 Blockade to Decrease irAEs (REPLAY)
Metastatic Melanoma
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Invasive Mammary Carcinoma, Metastatic Breast Cancer
RecruitingPhase 3
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
TNBC - Triple-Negative Breast Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Andreas D Flouris, PhD principal investigator
1FAME Laboratory, Department of Exercise Science, University of Thessaly, Trikala, Greece
Lars Nybo, PhD principal investigator
Department of Nutrition, Exercise and Sports, August Krogh Building, University of Copenhagen, Copenhagen, Denmark.
2 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study of Skin Cancer and Heat Tolerance, run by University of Thessaly at 2 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 3 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Denmark, Greece. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Maria Vliora, PhD (6979642540 ext. +30, mvliora@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Physiological Heat Tolerance (time frame: During 4-hour laboratory protocol). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2026.